# Patient-Directed Antimicrobial Duration in Acute Uncomplicated Pyelonephritis

> **NCT06127160** · PHASE4 · COMPLETED · sponsor: **Brett A Faine** · enrollment: 35 (actual)

## Conditions studied

- Pyelonephritis Acute

## Interventions

- **DRUG:** Cephalexin
- **DRUG:** Cephalexin or placebo

## Key facts

- **NCT ID:** NCT06127160
- **Lead sponsor:** Brett A Faine
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-06-04
- **Primary completion:** 2025-08-29
- **Final completion:** 2025-08-29
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2025-09-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06127160

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06127160, "Patient-Directed Antimicrobial Duration in Acute Uncomplicated Pyelonephritis". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06127160. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*